These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S. Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781 [Abstract] [Full Text] [Related]
3. PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development. Vadhan-Raj S. Stem Cells; 1994 May; 12(3):253-61. PubMed ID: 8075592 [Abstract] [Full Text] [Related]
8. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P. Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163 [Abstract] [Full Text] [Related]
12. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF, Chan HO. Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284 [Abstract] [Full Text] [Related]
13. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A. Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814 [Abstract] [Full Text] [Related]
17. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Gutschalk CM, Herold-Mende CC, Fusenig NE, Mueller MM. Cancer Res; 2006 Aug 15; 66(16):8026-36. PubMed ID: 16912178 [Abstract] [Full Text] [Related]
18. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients]. Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M. Pol Merkur Lekarski; 2007 Oct 15; 23(136):259-63. PubMed ID: 18293847 [Abstract] [Full Text] [Related]
19. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma. Ripley D, Tang XM, Ma C, Chegini N. Gynecol Oncol; 2001 May 15; 81(2):301-9. PubMed ID: 11330966 [Abstract] [Full Text] [Related]